For the 12% of adults in the U.S. now taking a weight-loss medication that targets the GLP-1 and/or GIP hormones to restrict ...
Amgen also tested MariTide in a population with Type 2 diabetes, a group that tends to lose less weight with the new obesity ...
More than seven million additional Americans could get coverage for popular drugs such as Zepbound and Wegovy under the ...
In the largest study to date on the effects of the drugs on the kidneys, researchers found GLP-1s help the protect the organs ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover Wegovy and Zepbound ...
The Biden administration said it would allow the program to pay for GLP-1 anti-obesity drugs, but the Trump administration ...
On Tuesday, the Biden administration announced plans to provide coverage for costly anti-obesity medications, including ...
The Biden administration is proposing to expand coverage of anti-obesity medicines for those with Medicare and Medicaid.
The Biden administration wants to expand coverage of anti-obesity medications to millions on Medicare, Medicaid ...
The Biden administration is proposing a major expansion of how Medicare and Medicaid cover the weight-loss drugs Wegovy and ...
Millions of Americans would be eligible to have costly weight-loss drugs like Wegovy or Ozempic covered by Medicare or ...
President Biden proposed on Tuesday that Medicare and Medicaid cover expensive weight-loss drugs like Wegovy or Ozempic under ...